On September 10, 2021 Aurinia Pharmaceuticals Inc. reported that members of the senior management team will participate in the H.C. Wainwright & Co. 23rd Annual Global Investment Conference, September 13-15, 2021 (Press release, Aurinia Pharmaceuticals, SEP 10, 2021, https://ir.auriniapharma.com/news/detail/235/aurinia-pharmaceuticals-to-participate-in-h-c-wainwright-23rd-annual-global-investment-conference [SID1234587514]). The Aurinia presentation will be available on-demand beginning September 13, 2021 at 3 pm ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The audio webcast is available here. Interested parties can also register and access the presentation under "News/Events" through the "Investors" section of the Aurinia corporate website at www.auriniapharma.com. A replay of the webcast will be available on Aurinia’s website.